Clinical trial
Impact of Hemo-dialysis Therapy on Blood Levels of Treprostenil in End Stage Renal Disease Patients With Pulmonary Hypertension
NCT01234571 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Hemo-dialysis Therapy on Blood Levels of Treprostenil in End Stage Renal Disease Patients With Pulmonary Hypertension
- Lead sponsor
- Rambam Health Care Campus
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2010
- Completion date
- Not reported
- Enrollment
- 5 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease, hemo-dialysis therapy, pulmonary hypertension